Omeros Corp (OMER) stock
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
$14.55+0.63 (+4.53%)
Close on Nov 18, 2026Market cap $1.05BP/E –Yield –
Omeros revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Omeros's revenue for the twelve months ending Mar 31, 2021 was $71.34M, down 37.2% year over year. For fiscal 2020 it was $73.81M, down 34.0% from the year before. Over ten years it grew 42.7% a year on average. The highest annual figure on record is $111.81M in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $73.81M | -34.0% |
| FY2019 | Dec 31, 2019 | $111.81M | +274.3% |
| FY2018 | Dec 31, 2018 | $29.87M | -53.9% |
| FY2017 | Dec 31, 2017 | $64.83M | +55.8% |
| FY2016 | Dec 31, 2016 | $41.62M | +208.1% |
| FY2015 | Dec 31, 2015 | $13.51M | +2406.3% |
| FY2014 | Dec 31, 2014 | $539.00K | -66.3% |
| FY2013 | Dec 31, 2013 | $1.60M | -73.4% |
| FY2012 | Dec 31, 2012 | $6.02M | +33.1% |
| FY2011 | Dec 31, 2011 | $4.52M | +114.9% |
| FY2010 | Dec 31, 2010 | $2.11M | +45.8% |
| FY2009 | Dec 31, 2009 | $1.44M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $28.53M | +35.5% |
| Q1 FY2026 | Mar 31, 2026 | $9.89M | -7.0% |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q1 FY2021 | Mar 31, 2021 | $21.06M | -10.5% |
| Q4 FY2020 | Dec 31, 2020 | $10.63M | -68.2% |
| Q3 FY2020 | Sep 30, 2020 | $26.11M | -12.5% |
| Q2 FY2020 | Jun 30, 2020 | $13.53M | -49.4% |
| Q1 FY2020 | Mar 31, 2020 | $23.54M | +8.1% |
| Q4 FY2019 | Dec 31, 2019 | $33.42M | +51.8% |
| Q3 FY2019 | Sep 30, 2019 | $29.86M | +547.9% |
| Q2 FY2019 | Jun 30, 2019 | $26.75M | +1516.5% |
| Q1 FY2019 | Mar 31, 2019 | $21.78M | +1271.5% |
| Q4 FY2018 | Dec 31, 2018 | $22.02M | +60.0% |
| Q3 FY2018 | Sep 30, 2018 | $4.61M | -78.7% |
| Q2 FY2018 | Jun 30, 2018 | $1.66M | -90.4% |
| Q1 FY2018 | Mar 31, 2018 | $1.59M | -87.0% |
| Q4 FY2017 | Dec 31, 2017 | $13.76M | +6.6% |
| Q3 FY2017 | Sep 30, 2017 | $21.66M | +91.9% |
| Q2 FY2017 | Jun 30, 2017 | $17.15M | +71.4% |
| Q1 FY2017 | Mar 31, 2017 | $12.26M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.91M | – |
| Q3 FY2016 | Sep 30, 2016 | $11.29M | – |
| Q2 FY2016 | Jun 30, 2016 | $10.00M | – |
See a number that looks wrong?